Jan 22
MiNT UK 2025 Early Bird Sale
Don’t Miss Out: MiNT UK 2025 Early Bird Ticket Sale Ends 28th February 2025!
Are you ready to dive into the future of neurotechnology and gain insights from leading experts in the field? MiNT UK 2025, Neurotechnology in Practice: Measuring Impact on Patient Outcomes, the premier event for the use of technology in rehabilitation, is just around the corner. We’ve got great news for you, our Early Bird ticket sale is currently underway! But don’t wait too long, this exclusive offer ends on the 28th February 2025.
Why Attend MiNT UK 2025?
MiNT UK 2025 is more than just a conference. It’s a unique opportunity to:
Discover Cutting-Edge Solutions: Explore the latest advancements in technology and how they can improve patient outcomes
Connect with Industry Leaders: Meet innovators, researchers, and clinicians who are shaping the future of neurotechnology
Discover Cutting-Edge Solutions: Explore the latest advancements in technology and how they can improve patient outcomes
Gain Practical Knowledge: Attend hands-on workshops and sessions designed to equip you with the skills to implement neurotechnological solutions in your practice
Network with Peers: Exchange ideas and experiences with professionals from various sectors of neurorehabilitation
What’s in Store?
This year, MiNT UK 2025 promises an exciting lineup of keynote speakers, panel discussions, and interactive exhibits. You’ll have the chance to:
- Hear from leading experts in neurotechnology
- Participate in innovative workshops
- Visit Showcase and Spotlight Exhibitors, featuring the latest technologies and solutions
- Engage in thought-provoking discussions about the impact of neurotechnology on patient outcomes
- Participate in the Poster Competition, showcasing cutting-edge research in the field
Our full programme and list of distinguished speakers will be announced soon! We invite you to stay updated by regularly checking our website and following our social media channels. This year's event promises to be more expansive and impactful than ever before, offering unparalleled opportunities to explore the latest advancements in neurotechnology.
Early Bird Pricing, Ends 28th February 2025
Take advantage of the Early Bird discount to secure your spot at MiNT UK 2025. This offer provides you with a significant saving compared to the standard ticket price. Don’t miss this chance to be part of an event that promises to be both informative and transformative.
Early Bird Price: £99.00 (Save £66.00)
Standard Price: £165.00
How to Get Your Early Bird Ticket
Getting your Early Bird ticket is simple:
1. Visit our official EventBrite page
2. Click on the ‘Get Tickets’ button
3. Finalise your payment, and you’re all set to join us in October!
Final Thoughts
MiNT UK 2025 is an event you won’t want to miss, especially if you’re passionate about the future of neurotechnology and its application in clinical practice. With the Early Bird sale ending on 28th February 2025, now is the perfect time to secure your ticket and ensure you’re part of this groundbreaking event.
We look forward to welcoming you to MiNT UK 2025 at CentrEd at ExCel in London. Let’s shape the future of neurotechnology together!
Connect with us
Copyright© 2022 Hobbs Rehabilitation LTD
Alison Watt
Head of Clinical Operations
Alison is Head of Clinical Operations for The MiNT Academy. With over 10 years of clinical experience within specialist neurological services, Alison previously worked in the NHS specialising in stroke and neurorehabilitation.
As a previous NHS AHP Ward Manager, Alison has always worked within innovative therapy roles. This continues at The MiNT Academy, a growing neurotechnology platform combining clinical education and product development.
As a previous NHS AHP Ward Manager, Alison has always worked within innovative therapy roles. This continues at The MiNT Academy, a growing neurotechnology platform combining clinical education and product development.
Alison coordinates research, development and education activities to enable increased accessibility to clinically effective devices.
As Principle Investigator in technology trials, she has aided the development of devices from concept to market, with recent focusses on Virtual Reality and Exoskeletons. Alison has presented at and organised numerous national and international conferences, including as MiNT Chair at RehabWeek 2022. She has also completed a Post-Graduate Certificate in Medical Education and lectures at multiple UK academic institutions.
Alongside this, Alison works clinically at Hobbs Rehabilitation Intensive Neurotherapy Centre in Bristol, combining the use of therapy devices with conventional hands-on treatment, for outpatients with a variety of neurological conditions. Alison uses all of her roles to passionately drive forward the use of neurotechnology in clinical practice to optimise opportunities and outcomes for patients.
As Principle Investigator in technology trials, she has aided the development of devices from concept to market, with recent focusses on Virtual Reality and Exoskeletons. Alison has presented at and organised numerous national and international conferences, including as MiNT Chair at RehabWeek 2022. She has also completed a Post-Graduate Certificate in Medical Education and lectures at multiple UK academic institutions.
Alongside this, Alison works clinically at Hobbs Rehabilitation Intensive Neurotherapy Centre in Bristol, combining the use of therapy devices with conventional hands-on treatment, for outpatients with a variety of neurological conditions. Alison uses all of her roles to passionately drive forward the use of neurotechnology in clinical practice to optimise opportunities and outcomes for patients.
Helen Hobbs
The MiNT Academy Development Team
Helen is a specialist neurological physiotherapist with over 25 years of specialist clinical experience and extensive clinical skills including advanced Bobath training. She has a special interest inclinical education, training and research. Helen has held postgraduate clinical training roles at both Kings College NHS Hospital London Neuroscience Centre and Southampton University Hospital NHS Trust before establishing Hobbs Rehabilitation in 2005.
Helen's teaching and leadership skills resulted in international scholarships and fellowships taking Helen to the USA and South Africa. She has presented both nationally and internationally. Helen has close links with several academic institutions including Southampton, Imperial College, Loughborough , Portsmouth and Winchester Universities to provide clinical leadership for the design of future healthcare technologies and research projects.
Her publications have included the effects of robotic assisted gait training on vascular health in strokes and spinal cord injured patients and the European rehabilitation guidelines for MS patients post stem cell transplant.
Amy Dennis-Jones
The MiNT Academy Research Lead
Amy has over 20 years experience working within the field of Neurological rehabilitation. She has worked with a variety of settings capturing the full rehabilitation pathway from acute through to the community.
Since working for Hobbs Rehabilitation in 2015, Amy has worked with an array of neurotechnologies and is a trained Rewalk exoskeleton clinician. She has presented at varying conference and study days, and is on the local committee for ACPIN, a specialist interest group for physiotherapists working in Neurology.
Amy's position within Hobbs Rehabilitation has evolved into a split clinical and research role. She is part of the core development team working on MiNT, an innovative neurotechnology platform combining clinical education and product development as well as leading on research projects and further collaborations.
Outside of physiotherapy, Amy is a qualified yoga teacher and combines her experience with rehabilitation to teach chair/adaptive yoga classes.
Chrissy Bibby
The MiNT Academy Events Lead
Chrissy has worked in the field of adult acquired neurological speech and language therapy for over 15 years, initially in the NHS before joining Hobbs Rehabilitation, where she leads the Speech & Language therapy team. Clinically, she has a special interest in motor speech disorders and rehabilitation of the facial nerve.
Chrissy trained as a teacher before embarking on her career in neurological rehabilitation and enjoys using her teaching skills in all areas of her work with Hobbs Rehabilitation and MiNT.
As Events Lead for The MiNT Academy, Chrissy is embracing the opportunity to discuss with fellow clinicians, academics and industry partners the benefits of using neurotechnology with our communication impaired clients, while encouraging further development in this vital area.
Outside of speech and language therapy, Chrissy enjoys swimming, singing with her local rock choir, baking, sewing, and camping with her family.
Chrissy trained as a teacher before embarking on her career in neurological rehabilitation and enjoys using her teaching skills in all areas of her work with Hobbs Rehabilitation and MiNT.
As Events Lead for The MiNT Academy, Chrissy is embracing the opportunity to discuss with fellow clinicians, academics and industry partners the benefits of using neurotechnology with our communication impaired clients, while encouraging further development in this vital area.
Outside of speech and language therapy, Chrissy enjoys swimming, singing with her local rock choir, baking, sewing, and camping with her family.
Laura Marriott
The MiNT Academy Education Lead
Laura is a specialist Neurological Occupational Therapist with 15 years of experience, over 12 years of which is in the neurological sector. Laura has worked in the NHS from acute care through to community rehabilitation and outpatients and now works in the private sector where she is the lead Occupational Therapist for Hobbs Intensive outpatient rehabilitation service, coordinating intensive rehabilitation packages and treating patients with complex neurological requirements.
Her role within Hobbs has evolved and she has split clinical and research responsibilities. She is part of the MiNT Academy Development Team who have delivered an innovative neurotechnology platform combining clinical education and product development. Her role also involves leading on research projects and further collaborations. Laura has expert clinical skills used to implement neuro assistive and rehabilitation technology into functional contexts building the links between the companies and the patients. Laura presented at Virtual RehabWeek 2021 and is excited to be presenting at RehabWeek 2022 in Rotterdam, showcasing the merits and application of collaboration between skilled clinicians and engineers to create a device that has longevity with both clinicians and patients alike.
Outside of Hobbs Laura enjoys a busy family life, hiking, roller skating and painting.
Lizzie Williams
The MiNT Academy Development Team
Lizzie is a Specialist Neurological Physiotherapist working at Hobbs Rehabilitation since May 2020. She also has a background in orthopaedics, frailty and inpatient rehabilitation. Lizzie jumped at the opportunity to be involved in The MiNT Academy to combine her interest in technology and love for providing high quality rehabilitation for patients. Lizzie brings the perspective of a physiotherapist who routinely utilises neurotechnology with patients as well as teaching and supporting other clinicians in embedding it into practice.
Rachael Edwards
The MiNT Academy Development Team
Rachael Edwards developed a specialist interest in the role of technology in upper limb neurorehabilitation, whilst working as an Occupational Therapist on the upper limb program at The National Hospital for Neurology and Neurosurgery, Queen Square.
Rachael has relocated to Bristol and is setting up an Occupational Therapy service at Hobbs Rehabilitation Intensive Neurotherapy Centre, where she continues to explore the use of technology to support delivering intensive upper limb rehabilitation.
Louis Martinelli
The MiNT Academy Development Team
With degrees in Sport & Exercise Science
(BSc) and Physiotherapy (MSc pre-registration), Louis has over ten years’ experience of working in neurological rehabilitation and 15 years in the exercise industry.
Trained in both the Ekso GT and ReWalk, Louis has been using exoskeletons on a daily basis with a variety of medical conditions at Hobbs Rehabilitation for seven years. He has also experienced many patient trials/assessments in a variety of other exoskeleton manufactures.
Louis has helped establish a research partnership between Hobbs Rehabilitation and The University of Winchester, which in 2019 published an article on the effects exoskeleton rehabilitation can have on the vascular system in the Journal of Spinal Cord Medicine.
(BSc) and Physiotherapy (MSc pre-registration), Louis has over ten years’ experience of working in neurological rehabilitation and 15 years in the exercise industry.
Trained in both the Ekso GT and ReWalk, Louis has been using exoskeletons on a daily basis with a variety of medical conditions at Hobbs Rehabilitation for seven years. He has also experienced many patient trials/assessments in a variety of other exoskeleton manufactures.
Louis has helped establish a research partnership between Hobbs Rehabilitation and The University of Winchester, which in 2019 published an article on the effects exoskeleton rehabilitation can have on the vascular system in the Journal of Spinal Cord Medicine.
Barry Richards
Head of Commercial Operations
Barry brings extensive expertise in the medical device industry and healthcare markets from across Europe, North America, and Asia Pacific. Renowned as a subject matter expert, he possesses deep knowledge of exoskeleton technology and the neurological MedTech rehabilitation sector.
With over a decade of commercial experience, Barry has worked with leading neurological rehabilitation MedTech companies in various roles, including clinical, business development, market access, and commercial operations. He has successfully assisted multiple organisations in shaping their business development, sales, marketing, and clinical strategy plans at different stages of commercialisation.
With over a decade of commercial experience, Barry has worked with leading neurological rehabilitation MedTech companies in various roles, including clinical, business development, market access, and commercial operations. He has successfully assisted multiple organisations in shaping their business development, sales, marketing, and clinical strategy plans at different stages of commercialisation.
Barry has held director-level and senior management positions at both global and European levels. He also has a strong clinical background in physiotherapy, with significant experience in the neurological rehabilitation field, and demonstrates a high level of competency in operating advanced technologies.
Created with
